INTRA-LUMINAL INTERLEUKIN (IL)-27 IS A POTENTIAL FUTURE THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE

被引：1
|
作者：
McLean, M. H. [1 ]
Hanson, M. L. [1 ]
Gold, B. [2 ]
Golubeva, Y. [3 ]
Anver, M. R. [3 ]
Wu, X. [4 ]
Sun, D. [4 ]
Steidler, L. [5 ]
Durum, S. K. [1 ]
机构：
[1] NCI, Canc & Inflammat Program, Bethesda, MD 20892 USA
[2] NCI, Human Genet Sect, Bethesda, MD 20892 USA
[3] Leidos Biomedical Res Inc, Lab Anim Sci Program, Frederick Natl Lab Canc Res, Frederick, MD USA
[4] Leidos Biomedical Res Inc, Lab Mol Technol, Frederick Natl Lab Canc Res, Frederick, MD USA
[5] ActoGenix NV, Zwijnaarde, Belgium
来源：
GUT | 2014年 / 63卷
关键词：
D O I：
10.1136/gutjnl-2014-307263.177
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
PTU-103
引用
收藏
页码：A84 / A84
页数：1
相关论文
共 50 条
  • [1] Intra-Luminal Interleukin (IL)-27 Ameliorates Acute Murine TNBS Colitis - A Potential Future Human Therapeutic for Inflammatory Bowel Disease?
    McLean, Mairi H.
    Hanson, Miranda L.
    Steidler, Lothar
    Anver, Miriam R.
    Shen, Wei
    Durum, Scott K.
    GASTROENTEROLOGY, 2013, 144 (05) : S33 - S33
  • [2] LACTOCOCCUS LACTIS EXPRESSING IL-27: A POTENTIAL THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE
    Hanson, M. L.
    Hixon, J. A.
    Li, W.
    Felber, B. K.
    Anver, M. R.
    Stewart, C. A.
    Shen, W.
    Steidler, L.
    Durum, S. K.
    INFLAMMATION RESEARCH, 2012, 61 : S15 - S16
  • [3] Lactococcus lactis expressing IL-27: A potential therapeutic for inflammatory bowel disease
    Hanson, Miranda L.
    Hixon, Julie A.
    Li, Wenqing
    Felber, Barbara K.
    Anver, Miriam R.
    Stewart, Charles A.
    Shen, Wei
    McLean, Mairi
    Rottiers, Pieter
    Steidler, Lothar
    Durum, Scott K.
    CYTOKINE, 2013, 63 (03) : 269 - 269
  • [4] Lactococcus lactis expressing IL-27: A potential therapeutic for inflammatory bowel disease
    Hanson, Miranda L.
    Nixon, Julie A.
    Li, Wenqing
    Felber, Barbara K.
    Anver, Miriam R.
    Steidler, Lothar
    Durum, Scott K.
    CYTOKINE, 2010, 52 (1-2) : 22 - 23
  • [5] LACTOCOCCUS LACTIS EXPRESSING IL-27: A POTENTIAL THERAPEUTIC FOR INFLAMMATORY BOWEL DISEASE (IBD)
    Hanson, Miranda
    Hixon, Julie
    Li, Wenqing
    Felber, Barbara
    Anver, Miriam
    Steidler, Lothar
    Durum, Scott
    INFLAMMATION RESEARCH, 2010, 59 : S301 - S301
  • [6] Role of Interleukin 27 (IL-27) in the Colonic Mucosa of Patients With Inflammatory Bowel Disease
    Yamamoto-Furusho, Jesus K.
    Fonseca-Camarillo, Gabriela
    Furuzawa-Carballeda, Janette
    GASTROENTEROLOGY, 2015, 148 (04) : S692 - S692
  • [7] Role of Interleukin 27 (IL-27) in the Colonic Mucosa of Patients with Inflammatory Bowel Disease.
    Fonseca Camarillo, G.
    Janette, F. -C.
    Jesus Kazuo, Y. F.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S88 - S89
  • [8] Lactococcus lactis expressing IL-27: Therapeutic promise in inflammatory bowel disease
    Durum, Scott K.
    Li, Wen Qing
    Hixon, Julie A.
    Felber, Barbara
    Steidler, Lothar
    Hanson, Miranda L.
    CYTOKINE, 2010, 52 (1-2) : 11 - 11
  • [9] Research Progress of Interleukin-27 in Inflammatory Bowel Disease
    Wang, Qing
    Chen, Feifan
    Peng, Yingqiu
    Yi, Xuanyu
    He, Yu
    Shi, Yuan
    INFLAMMATORY BOWEL DISEASES, 2024, 30 (02) : 303 - 310
  • [10] Inflammatory bowel disease: Potential therapeutic strategies
    Nielsen, OH
    Vainer, B
    Bregenholt, S
    Claesson, MH
    Bishop, PD
    Kirman, I
    CYTOKINES CELLULAR & MOLECULAR THERAPY, 1997, 3 (04) : 267 - 281
12345